Radka Tomšič

Involved-field radiotherapy for advanced Hodgkin's lymphoma.

J. Raemaekers, A. Hagenbeek, J. Baars, 2003, The New England journal of medicine.

Rituximab affects the prognosis of patients with nonHodgkin' s lymphomas

S. Borstnar, M. Vovk, B. Novakovič, 2004 .

Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884

A. Hagenbeek, C. Sebban, U. Tirelli, 2001 .

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

M. Kersten, A. Hagenbeek, G. Salles, 2009, The Lancet. Oncology.

Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).

J. Raemaekers, E. Noordijk, Y. Lievens, 2005, International journal of radiation oncology, biology, physics.